Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  FUJIFILM Holdings Corporation    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
End-of-day quote. End-of-day quote Tokyo Stock Exchange - 08/06
4845 JPY   +0.64%
08/05India's Lupin to sell generic COVID-19 drug favipiravir
RE
08/05India's Lupin to sell generic COVID-19 drug favipiravir
RE
08/04Sun Pharma latest to sell COVID-19 drug favipiravir in India
RE
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
07/31/2020 08/03/2020 08/04/2020 08/05/2020 08/06/2020 Date
4717 4778 4833 4814 4845 Last
1912600 1919500 1590900 1866100 1631800 Volume
-1.09% +1.29% +1.15% -0.39% +0.64% Change
Financials
Sales 2021 2 251 B 21 327 M 21 327 M
Net income 2021 128 B 1 213 M 1 213 M
Net cash position 2021 277 B 2 625 M 2 625 M
P/E ratio 2021 14,9x
Yield 2021 2,03%
Sales 2022 2 386 B 22 610 M 22 610 M
Net income 2022 157 B 1 491 M 1 491 M
Net cash position 2022 327 B 3 094 M 3 094 M
P/E ratio 2022 12,0x
Yield 2022 2,15%
Capitalization 1 924 B 18 251 M 18 233 M
EV / Sales 2021 0,73x
EV / Sales 2022 0,67x
Nbr of Employees 73 906
Free-Float 73,7%
More Financials
Company
Fujifilm Holdings Corporation specializes in the manufacturing and marketing of printing, imaging and photography materials and equipment. Net sales break down by activity as follows: - sale of printers and photocopiers (42.7%); - sale of medical imaging equipment (41.4%): digital endoscopes, digital mammography devices, radiologic tables, ultrasound scan systems, etc. The group also develops pharmaceutical... 
Sector
Office Equipment
Calendar
08/13Earnings Release
More about the company
Surperformance© ratings of FUJIFILM Holdings Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on FUJIFILM HOLDINGS CORPORAT
08/05India's Lupin to sell generic COVID-19 drug favipiravir
RE
08/05India's Lupin to sell generic COVID-19 drug favipiravir
RE
08/04Sun Pharma latest to sell COVID-19 drug favipiravir in India
RE
07/29India's Hetero wins approval to sell COVID-19 drug favipiravir
RE
07/28After early hype, Japan's homegrown COVID-19 drug hope Avigan faces rocky fut..
RE
07/28FUJIFILM : Japan's Fujifilm gets $265 million U.S. contract to boost output of p..
RE
07/24Cipla gets India approval to sell COVID-19 drug favipiravir
RE
07/24NOVAVAX : Fujifilm affiliate, Novavax to make COVID-19 vaccine candidate
AQ
07/21India's Glenmark defends price of its COVID-19 drug favipiravir version
RE
07/20FUJIFILM : Disaster Relief Donation for People Affected by the Heavy Rain Event ..
AQ
07/18FUJIFILM : to start clinical study of COVID-19 drug Avigan in Kuwait
AQ
07/13India's Glenmark cuts price of COVID-19 drug favipiravir version to $1/tablet
RE
07/13Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet
RE
07/10Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio
AQ
07/10UPDATE1 : Avigan study fails to demonstrate benefit in COVID-19 treatment
AQ
More news
News in other languages on FUJIFILM HOLDINGS CORPORAT
08/05India's Lupin to sell generic COVID-19 drug favipiravir
08/05India's Lupin to sell generic COVID-19 drug favipiravir
08/04Sun Pharma latest to sell COVID-19 drug favipiravir in India
07/29India's Hetero wins approval to sell COVID-19 drug favipiravir
07/28After early hype, Japan's homegrown COVID-19 drug hope Avigan faces rocky fut..
More news
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FUJIFILM HOLDINGS CORPORAT
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 5 855,47 JPY
Last Close Price 4 814,00 JPY
Spread / Highest target 41,3%
Spread / Average Target 21,6%
Spread / Lowest Target -12,8%
EPS Revisions
Managers
NameTitle
Shigetaka Komori Chairman & Group Chief Executive Officer
Kenji Sukeno President, Group COO & Representative Director
Takashi Iwasaki Director & Chief Technology Officer
Kouichi Tamai Director & Vice President
Takatoshi Ishikawa Director
Sector and Competitors
1st jan.Capitalization (M$)
FUJIFILM HOLDINGS CORPORATION-7.95%18 251
CANON INC.-40.38%17 660
RICOH COMPANY, LTD.-40.18%4 899
BROTHER INDUSTRIES, LTD.-26.95%4 089
SEIKO EPSON CORPORATION-28.46%3 885
TOSHIBA TEC CORPORATION-6.53%2 203